Staff Product Manager, Genomics GenAI at Tempus

Chicago, Illinois, United States

Tempus Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Healthcare, BiotechnologyIndustries

Requirements

  • Seasoned, highly autonomous, and technically proficient self-starter
  • Thrives in deeply ambiguous and intensely cross-functional settings
  • Ability to serve as a thought leader and key influencer
  • Experience partnering closely with diverse internal teams including lab operations, bioinformatics, clinical, legal, reporting, and core software engineering
  • Passionate about precision medicine, transforming healthcare with AI, particularly Generative AI in genomics

Responsibilities

  • Define and champion the long-term strategic vision for GenAI tools within Genomics engineering and broader product organization, aligning with Tempus’s genomics, AI, and company-wide strategies
  • Translate complex scientific and technical challenges into clear, actionable product strategies and GenAI-driven solutions addressing pain points and unlocking new capabilities
  • Identify and drive architectural shifts and foundational improvements leveraging GenAI to enhance efficiency, accuracy, and scalability across the genomics platform
  • Proactively identify and validate new frontiers for GenAI application in genomics to create novel, high-impact product offerings
  • Lead the end-to-end product lifecycle for complex GenAI solutions, from ideation, technical prototyping, and experimentation to deployment, adoption, and optimization
  • Collaborate deeply with core product and engineering teams, providing technical guidance and strategic direction to design, develop, and implement GenAI-powered tools and workflows
  • Drive significant system enhancements utilizing GenAI to improve turnaround time for launching assays and reduce manual work in test production, focusing on measurable business impact
  • Leverage advanced analytics, deep user insights, and industry trends to propose, champion, and lead transformative improvements to core genomics infrastructure and tooling through GenAI applications
  • Architect and refine transformative GenAI workflows
  • Own mission-critical, 0-to-1 launches from conception through delivery

Skills

Generative AI
Genomics
Product Management
Bioinformatics
Precision Medicine
AI Platforms
Healthcare AI
Lab Operations
Software Engineering
Cross-functional Collaboration

Tempus

AI-driven healthcare data analysis platform

About Tempus

Tempus focuses on enhancing patient outcomes through the use of data and artificial intelligence in healthcare. The company offers a platform that analyzes medical data to provide insights for physicians, helping them make better treatment decisions. This platform also aids pharmaceutical and biotech companies in drug development by identifying new targets and assessing treatment effectiveness. For patients, Tempus identifies personalized therapy options, particularly in cancer care, where their research has shown increased opportunities for tailored treatments. They have developed a pan-cancer organoid platform and a liquid biopsy assay for profiling circulating tumor DNA. Tempus generates revenue by charging healthcare providers and companies for access to their platform and insights, setting them apart from competitors by their focus on personalized medicine and extensive cancer research.

Chicago, IllinoisHeadquarters
2015Year Founded
$894.9MTotal Funding
IPOCompany Stage
AI & Machine Learning, Biotechnology, HealthcareIndustries
1,001-5,000Employees

Benefits

Relocation Assistance
Company Equity
Performance Bonus

Risks

Competition from partners like Genialis may lead to conflicts of interest.
Ambry Genetics acquisition could pose financial risks if synergies aren't realized.
Technical challenges may arise in integration with Flatiron's OncoEMR platform.

Differentiation

Tempus uses AI to analyze clinical and molecular data for precision medicine.
Their platform aids in personalized treatment decisions for cancer patients.
Tempus collaborates with biotech firms to enhance drug development using real-world data.

Upsides

Increased AI adoption in healthcare boosts Tempus' partnerships and collaborations.
Acquisition of Ambry Genetics expands Tempus' genetic testing capabilities.
Integration with Flatiron's OncoEMR enhances precision in cancer treatment plans.

Land your dream remote job 3x faster with AI